Sponsored by Dr. Gunjan Raina

Over the past few years, GLP-1 medications have become household names. Drugs such as semaglutide and tirzepatide have transformed the conversation around weight management, but what many people do not realize is that these medications are far from new.

GLP-1 therapies have been used for nearly two decades in the treatment of Type 2 diabetes. Long before they became popular for weight loss, physicians were prescribing them to help patients improve blood sugar control, reduce complications from diabetes and support overall metabolic health. Because of their long history of use, these medications are among the most extensively studied treatments in modern medicine.

One of the biggest misconceptions surrounding GLP-1 medications is that they are simply “weight loss drugs.” While weight reduction is certainly one benefit, these medications offer much more. Research has shown that GLP-1 therapies can improve blood sugar regulation, reduce insulin resistance, lower inflammation, improve cardiovascular health and decrease the risk of heart attacks, strokes and cardiovascular death in high-risk individuals. Some studies have also demonstrated benefits in kidney disease, fatty liver disease, sleep apnea and other obesity-related conditions.

Weight loss itself is not merely a cosmetic issue. Excess body weight is associated with diabetes, high blood pressure, elevated cholesterol, arthritis, sleep apnea, heart disease and certain cancers. By helping patients achieve and maintain a healthier weight, GLP-1 medications can significantly improve both quality of life and long-term health outcomes.

Another common concern is the belief that using a GLP-1 medication is somehow “cheating.” The reality is that obesity is a complex medical condition influenced by genetics, hormones, metabolism, environment, stress, sleep and lifestyle factors. For many individuals, weight regulation is far more complicated than simply eating less and exercising more.

Using a GLP-1 medication is not taking the easy way out — it is using evidence-based medical science to address underlying biological factors that make weight loss difficult. We do not consider blood pressure medication cheating when someone has hypertension, nor do we consider insulin cheating when someone has diabetes. GLP-1 therapies should be viewed through the same lens: as medical tools designed to treat a chronic disease.

At HEAL, we view GLP-1 medications as one piece of a comprehensive wellness strategy. The most successful outcomes occur when these medications are combined with strength training, adequate protein intake, healthy nutrition, quality sleep, stress management and ongoing medical support. The goal is not simply to lose weight but to improve body composition, preserve muscle mass, reduce disease risk and create sustainable long-term health.

As we move through 2026, GLP-1 medications continue to redefine how we approach obesity, diabetes and metabolic disease. They represent one of the most important advances in preventive medicine in recent decades. When used appropriately and under medical supervision, they are safe, effective and can be life-changing for many patients seeking to improve their health and longevity.